Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratympanic Injections”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableStudy completedNCT06885723
What this trial is testing

Use of Vibration Anesthesia Device in Intratympanic Injections

Who this might be right for
Intratympanic InjectionsSudden Hearing Loss
Yuzuncu Yil University 40
Testing effectiveness (Phase 2)Ended earlyNCT02740387
What this trial is testing

Open Label Study of OTO-104 in Subjects With Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 34
Testing effectiveness (Phase 2)Study completedNCT02265393
What this trial is testing

A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom

Who this might be right for
Meniere's Disease
Otonomy, Inc. 128
Large-scale testing (Phase 3)Study completedNCT02612337
What this trial is testing

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 166
Early research (Phase 1)Study completedNCT04629664
What this trial is testing

FX-322 in Adults With Severe Sensorineural Hearing Loss

Who this might be right for
Hearing Loss, SensorineuralNoise Induced Hearing LossSudden Hearing Loss
Frequency Therapeutics 31
Testing effectiveness (Phase 2)Study completedNCT04129775
What this trial is testing

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

Who this might be right for
Sensorineural Hearing Loss
Otonomy, Inc. 110
Post-approval studies (Phase 4)Study completedNCT01372904
What this trial is testing

Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment

Who this might be right for
Cisplatin Ototoxicity
Meir Medical Center 30
Large-scale testing (Phase 3)Study completedNCT03508440
What this trial is testing

Intratympanic Steroid for Bell's Palsy

Who this might be right for
Bell's PalsyFacial Nerve Paresis
University of Missouri-Columbia 10
Not applicableNot Yet RecruitingNCT06213415
What this trial is testing

Role of Oral Steroid Alone Versus Oral Steroid Plus Intratympanic Steroid Injection in Bell's Palsy

Who this might be right for
Bell Palsy
Assiut University 42
Post-approval studies (Phase 4)Ended earlyNCT04226456
What this trial is testing

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Who this might be right for
Ototoxic Hearing LossOtotoxic Hearing Loss, BilateralOtotoxicity+1 more
Centre Hospitalier Universitaire Saint Pierre 19
Large-scale testing (Phase 3)Ended earlyNCT02768662
What this trial is testing

A 6-Month Extension Study of OTO-104 in Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 142
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Testing effectiveness (Phase 2)Study completedNCT04766853
What this trial is testing

Verification of the Efficacy/safety of the Intratympanic Drug Delivery for Hearing Loss

Who this might be right for
Hearing Loss, SuddenHearing Loss, OtotoxicHearing Loss, Noise-Induced+1 more
Seoul National University Hospital 15
Large-scale testing (Phase 3)Study completedNCT03664674
What this trial is testing

Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Who this might be right for
Meniere Disease
Otonomy, Inc. 148
Early research (Phase 1)Study completedNCT01084525
What this trial is testing

OTO-104 for Meniere's Disease

Who this might be right for
Meniere's Disease
Otonomy, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT03616223
What this trial is testing

FX-322 in Sensorineural Hearing Loss

Who this might be right for
Sensorineural Hearing Loss
Frequency Therapeutics 23
Testing effectiveness (Phase 2)Ended earlyNCT01526174
What this trial is testing

Intratympanic Injection for Autoimmune Inner Ear Disease

Who this might be right for
Autoimmune Inner Ear Disease
House Research Institute 16
Testing effectiveness (Phase 2)Study completedNCT04120116
What this trial is testing

FX-322 in Adults With Stable Sensorineural Hearing Loss

Who this might be right for
Sensorineural Hearing LossNoise Induced Hearing LossSudden Sensorineural Hearing Loss
Frequency Therapeutics 95
Testing effectiveness (Phase 2)UnknownNCT01108601
What this trial is testing

Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity

Who this might be right for
Hearing Loss
McGill University Health Centre/Research Institute of the McGill University Health Centre 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06437054
What this trial is testing

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

Who this might be right for
Hearing Loss, SensorineuralHearing Loss, SuddenIntratympanic Injection
Seoul National University Hospital 26
Load More Results